543 related articles for article (PubMed ID: 32311322)
1. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
Principi N; Esposito S
Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322
[No Abstract] [Full Text] [Related]
2. Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
Rathi S; Ish P; Kalantri A; Kalantri S
Lancet Infect Dis; 2020 Oct; 20(10):1118-1119. PubMed ID: 32311324
[No Abstract] [Full Text] [Related]
3. Chloroquine as a prophylactic agent against COVID-19?
Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
[TBL] [Abstract][Full Text] [Related]
4. Internet Searches for Unproven COVID-19 Therapies in the United States.
Liu M; Caputi TL; Dredze M; Kesselheim AS; Ayers JW
JAMA Intern Med; 2020 Aug; 180(8):1116-1118. PubMed ID: 32347895
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S; Das S; Jain A; Misra DP; Negi VS
Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
[TBL] [Abstract][Full Text] [Related]
6. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
Sahraei Z; Shabani M; Shokouhi S; Saffaei A
Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
[No Abstract] [Full Text] [Related]
7. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
D'Acquarica I; Agranat I
Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
[No Abstract] [Full Text] [Related]
8. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
Allam MF; Andraous F
Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
[No Abstract] [Full Text] [Related]
9. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
Patrì A; Fabbrocini G
J Am Acad Dermatol; 2020 Jun; 82(6):e221. PubMed ID: 32283237
[No Abstract] [Full Text] [Related]
10. Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19.
Cortegiani A; Ippolito M; Ingoglia G; Iozzo P; Giarratano A; Einav S
J Crit Care; 2020 Oct; 59():176-190. PubMed ID: 32683212
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
[TBL] [Abstract][Full Text] [Related]
12. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
Jakhar D; Kaur I
Nat Med; 2020 May; 26(5):632. PubMed ID: 32269358
[No Abstract] [Full Text] [Related]
13. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
Islam M
J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
[No Abstract] [Full Text] [Related]
14. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
Lebin JA; LeSaint KT
West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
[TBL] [Abstract][Full Text] [Related]
15. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
Yazdany J; Kim AHJ
Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
[No Abstract] [Full Text] [Related]
17. Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings.
Mvumbi DM
Med Hypotheses; 2020 Oct; 143():109912. PubMed ID: 32498009
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention.
Tarek M; Savarino A
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):715-723. PubMed ID: 32780273
[TBL] [Abstract][Full Text] [Related]
19. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
Piszczatoski CR; Powell J
Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025
[TBL] [Abstract][Full Text] [Related]
20. Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
Mehta S; Bhandari S; Mehta S
J Glob Antimicrob Resist; 2020 Sep; 22():864-865. PubMed ID: 32777441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
